Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery-Reference-Cited by-同舟云学术

Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery

Published:2019-10-10 Issue:12 Volume:8 Page:e1670019
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Sivakumar Ramya¹,Chan Marina¹,Shin Jiye Stella¹,Nishida-Aoki Nao¹,Kenerson Heidi L.²,Elemento Olivier³,Beltran Himisha⁴,Yeung Raymond²,Gujral Taranjit S.¹⁵^ORCID

Affiliation:

1. Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

2. Department of Surgery, University of Was hington, Seattle, WA, USA

3. Englander Institute of Precision medicine, Weill Cornell Medicine, NY, USA

4. Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

5. Department of Pharmacology, University of Washington, Seattle, WA, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1670019

Reference41 articles.

1. Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future

2. Three-dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo

3. Ex vivo tumor culture systems for functional drug testing and therapy response prediction

4. Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors

5. Tumor slice culture system to assess drug response of primary breast cancer

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application and prospect of organoid technology in breast cancer;Frontiers in Immunology;2024-08-26

2. Longitudinally cultured precision cut lung slices as a predictiveex vivomodel for lung cancer;2024-08-26

3. Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma;Cell Reports Medicine;2024-08

4. Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism;OncoImmunology;2024-07-09

5. Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients;Neuro-Oncology;2024-05-02